v-CJD in the future
Variant Creutzfeldt Jakob disease (v-CJD) was first defined in the UK in 1996. This POSTnote outlines the main factors that will influence the number of future cases, considers models that estimate the total number of deaths, and discusses the policy implications.
No abstract for this publication.
Publication type:
policy brief
Publication language:
English
Publication date:
2002-01
Publication URL:
https://post.parliament.uk/research-briefings/post-pn-171/
Institute:
Parliamentary Office of Science and Technology of the UK Parliament (POST)
Country:
United Kingdom of Great Britain & Northern Ireland

 Back